PDCD1 and neoplasm: In addition, depletion of CD8+ T cell with CD8 mAb also resulted in continued tumor growth and elevated tumor weight (Supplementary Fig. 7E), strongly suggesting that inhibiting TP63 synergistically enhances the anti-tumor effect of PD-1 mAb by enhancing CD8+ T cell infiltration and activity.